Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8300
+0.1500 (8.93%)
NASDAQ· Last Trade: Jun 19th, 6:30 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors